Bayron, Lou Rey Ann .
HRN: 27-94-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2026
CEFUROXIME 1.5GM (VIAL)
01/08/2026
01/10/2026
IV
1.5g
Q8h
S/P CS
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines